First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Volumn 26, Issue 2, 2004, Pages 119-121

  Guan, Zhong zhen ^a   Liu, Dong geng ^a   Yu, Bao ming ^a   Wu, Wei qin ^a   Shi, D ^a   Zhao, Y ^a   Wei, Yu quan ^a   Zou, Li qun ^a   Wu, Xiao ding ^a   Zhuang, Wen ^a   Feng, Feng yi ^a   Zhang, Pin ^a   Yu, Shi ying ^a   Xiong, Hui hua ^a   Fu, Qiang ^a   Zheng, Shu ^a   Huang, Jian jin ^a   Wu, Gang ^a   Yang, Chuan yong ^a   Sun, Sheng rong ^a   Ruan, Qing lan ^a   more..

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; SURVIVAL RATE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 2942518344     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)